What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “ORN252 is a lipid nanoparticle encapsulating a circular RNA encoding an anti-CD19 CAR protein.”In the company’s words, NCT07439796 on ClinicalTrials.gov
- Main trialPhase 1
- “The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.”In the company’s words, NCT07439796 on ClinicalTrials.gov
Coming up1
- DecPhase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | Dec 2026 | A Study of ORN252 in Healthy Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026